Aalto Bio Reagents, Dublin, Ireland, has released yellow fever monoclonal antibodies for diagnostic test manufacturers, vaccine developers, and researchers globally. The monoclonal antibodies are raised against cell-culture derived viral lysate from strain 17D. A potentially fatal mosquito-born flavivirus, yellow fever is common in tropical and subtropical locations in South America and Africa. Like such flaviruses as Dengue and Zika virus, transmission to humans in these regions is accomplished predominantly via the female Aedes aegypti mosquito. The antibodies are proven to detect yellow fever NS1 protein, and are unique in that they show no cross-reactivity with other flavivirus NS1 proteins, allowing very specific detection. For more information, visit Aalto Bio Reagents.